Revenue
0 USD
2016 Q3 · USD
Exact inputs and evidence
- Revenue: 0 USD Source
17 filing records in this dataset, filed from 2013-08-06 to 2017-07-19. Reported financial figures are available; chart coverage varies by period.
These figures cover less than a full year. They are not annualized and are excluded from full-year trends and comparisons.
| Measure | Period | Value |
|---|---|---|
| Net income | 2013-04-15 – 2013-05-31 | -651 USD Source Dispute |
| Operating cash flow | 2013-04-15 – 2013-05-31 | -651 USD Source Dispute |
| Operating expenses | 2013-04-15 – 2013-05-31 | 651 USD Source Dispute |
| Operating income | 2013-04-15 – 2013-05-31 | -651 USD Source Dispute |
| Revenue | 2013-04-15 – 2013-05-31 | 0 USD Source Dispute |
1435 USD
31900000 shares
-0.14% · -43.8 thousand shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2017-07-19.
Financial data available through: 2016-05-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
−USD 49,096
–
Current period
−USD 58,705
–
-58705 − -49096 = -9609 USD
-49096 USD · 2014-06-01 – 2015-05-31
Inspect prior input Prior source-58705 USD · 2015-06-01 – 2016-05-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 49,096
–
Current period
−USD 47,693
–
-47693 − -49096 = 1403 USD
-49096 USD · 2014-06-01 – 2015-05-31
Inspect prior input Prior source-47693 USD · 2015-06-01 – 2016-05-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2014 2013-06-01 – 2014-05-31 | 0 | 30395 Derived | -30395 | 0 Derived | -30395 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2014 | Revenue | 0 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2014 | Year over year | No prior comparable period |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2014 | Operating margin | Not reported |
|
| 2014 | Net margin | Not reported |
|
| 2014 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2014 | Operating cash flow | -30395 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2014 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2014-05-31 | Liabilities / assets | Not reported |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2014 | Current assets / current liabilities | 0.63× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2014 2013-06-01 – 2014-05-31 | −USD 30,395 Exact valueExact value: -30395 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 30,395 Exact valueExact value: -30395 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2015 2014-06-01 – 2015-05-31 | −USD 49,096 Exact valueExact value: -49096 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 49,096 Exact valueExact value: -49096 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2016 2015-06-01 – 2016-05-31 | −USD 58,705 Exact valueExact value: -58705 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 47,693 Exact valueExact value: -47693 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
17 filings · 596 latest values · 596 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001583671, 1583671, abxx, beut, edgar:1583671
Also known as Argan Beauty Corp., Science to Consumers, Inc.